Outset Medical (OM) Signs HCA Console Refresh Deal Through 2028

This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.

The short version

Outset Medical, Inc. (OM) entered into a "Refresh Amendment" with HCA Management Services, L.P. on June 15, 2026, extending their existing Tablo Hemodialysis purchasing agreement through December 31, 2028. The deal requires HCA-affiliated hospitals to purchase a specified number of new Tablo consoles during the refresh period, with pricing and minimum purchase schedules set out in the agreement. Key financial terms — including exact unit counts and prices — were redacted from the public filing.

Outset Medical, Inc. (Nasdaq: OM) disclosed on June 17, 2026 that it signed a contract renewal and expansion with HCA Management Services, L.P., the purchasing arm of HCA Healthcare, according to the company's 8-K filing (a report companies use to announce major news).

What the Deal Says

The agreement, called a "Refresh Amendment," updates an original purchasing contract the two companies signed on May 1, 2020, for Outset Medical's Tablo Hemodialysis system — a kidney dialysis machine. The amendment took effect June 15, 2026, and stretches the agreement's end date to December 31, 2028.

Under the deal, HCA-affiliated hospitals are required to buy a set number of new Tablo consoles (the main hardware unit) by December 31, 2028, with specific minimum purchase targets spread across shorter time windows within that period. The exact unit counts, prices, and purchase schedules were redacted (blacked out) from the public version of the filing.

Trade-Ins and Other Terms

Outset Medical agreed to provide a credit on each older console that an HCA facility trades in when buying a new one. The credit amount was also redacted. Existing rebate programs remain in place, and additional rebate terms were similarly redacted.

Notably, the filing states that HCA cannot cancel the agreement without cause during the refresh period — a term that locks in the purchasing relationship through 2028.

Outset Medical CEO Leslie Trigg and HCA's Todd Greener, COO of HealthTrust Purchasing Group, signed the amendment on June 11 and June 14, 2026, respectively.

What Was Left Out

Because this is a commercial contract between two companies, Outset Medical redacted the specific number of consoles to be purchased, the pricing tiers, and other financial details, citing confidentiality. No total dollar value for the contract was disclosed in the filing.

Key facts

Outset Medical (OM) signed a Refresh Amendment with HCA Management Services, L.P., effective June 15, 2026.

The agreement covers Outset Medical's Tablo Hemodialysis Consoles.

The original purchasing agreement dates to May 1, 2020.

The amended agreement runs through December 31, 2028.

HCA-affiliated facilities are required to purchase a minimum number of new Tablo consoles by December 31, 2028 — exact unit counts were redacted.

A trade-in credit is offered for older consoles replaced during the refresh period — credit amount redacted.

HCA cannot terminate the agreement without cause during the refresh period.

Signed by Outset Medical CEO Leslie Trigg (June 11, 2026) and HCA's Todd Greener, COO of HealthTrust Purchasing Group (June 14, 2026).

8-K filed with the SEC on June 17, 2026.

Why it matters

This amendment locks in a continued commercial relationship between Outset Medical and one of the largest hospital networks in the United States through the end of 2028, with a contractual ban on HCA canceling without cause during the refresh period. For a medical device company like Outset Medical, a multi-year committed purchase agreement with a major health system provides a degree of revenue visibility. However, because the unit volumes and pricing were fully redacted, investors cannot determine the financial size of this commitment from the public filing alone.

Frequently asked

What did Outset Medical agree to with HCA?

Outset Medical signed a contract update with HCA Management Services, L.P. that requires HCA-affiliated hospitals to buy a certain number of new Tablo dialysis consoles by December 31, 2028. The exact number and prices were kept confidential in the public filing.

How long does the new agreement last?

The agreement runs through December 31, 2028, extended from its prior expiration date by this amendment.

Can HCA walk away from this deal early?

According to the filing, HCA is not allowed to terminate the agreement without cause during the refresh period, which runs through December 31, 2028.

Who signed the agreement for each company?

Outset Medical CEO Leslie Trigg signed on June 11, 2026, and HCA's Todd Greener, COO of HealthTrust Purchasing Group, signed on June 14, 2026.

What the filing reported

1.01 Entry into a Material Agreement

2.02 Results of Operations & Financial Condition

9.01 Financial Statements & Exhibits